LABIANA HEALTH S.A.EO-10 (8RK) — Tangible Net Worth Ratio
LABIANA HEALTH S.A.EO-10 (8RK) has a Tangible Net Worth Ratio of -65.0% as of June 2025. This metric is calculated by deducting intangible assets (€5.95 Million) from net assets (€3.60 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See LABIANA HEALTH S.A.EO-10 (8RK) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
LABIANA HEALTH S.A.EO-10 Tangible Net Worth Ratio (2021–2024)
This chart shows how LABIANA HEALTH S.A.EO-10's Tangible Net Worth Ratio has changed across 4 annual periods from 2021 to 2024. As of June 2025, the ratio stands at -65.0%, reflecting net assets of €3.60 Million with intangible assets of €5.95 Million EUR. See 8RK defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for LABIANA HEALTH S.A.EO-10 (2021–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for LABIANA HEALTH S.A.EO-10 from 2021 to 2024, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see LABIANA HEALTH S.A.EO-10 (8RK) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -134.7% | €2.57 Million | €6.03 Million | €52.00 Million | ▼ -9.0 pp |
| 2023 | -125.6% | €3.40 Million | €7.68 Million | €59.12 Million | ▼ -94.7 pp |
| 2022 | -31.0% | €6.91 Million | €9.04 Million | €60.78 Million | ▼ -31.5 pp |
| 2021 | 0.5% | €11.52 Million | €11.46 Million | €68.37 Million | — |